IBEX
IBEX Limited
IBEX's outlook is improving, though it still trails on the overall score.
MSFT
Microsoft Corporation
MSFT has the edge over IBEX overall, supported by stronger modeled upside and stronger valuation.
IBEX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
IBEX's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
IBEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $33.48 | -39% |
| Fair | 13x | $42.92 | -22% |
| Forward | 14x | $54.87 | — |
| Current | 17x | $54.87 | — |
| Expensive | 20x | $66.14 | +21% |
Historical ranges are pointers, not guarantees.
IBEX's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over IBEX in the historical PE scenario, which offers more potential upside but is not a forecast.
IBEX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for IBEX, with profitability holding steady.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
IBEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.95 | +20% |
| Q3 2026 | $3.30 | +20% |
| Q2 2026 | $3.13 | +33% |
| Q1 2026 | $3.17 | +39% |
| Q4 2025 | $3.01 | +42% |
| Q3 2025 | $2.75 | +46% |
| Q2 2025 | $2.36 | +28% |
| Q1 2025 | $2.28 | +49% |
| Q4 2024 | $2.12 | +35% |
IBEX has the edge over MSFT on earnings, with stronger typical year-over-year growth.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT's earnings per share have climbed steadily: $19.15 over the past year, up 36% from the year before, and higher year over year for 14 quarters in a row.
IBEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $175.2M | +16% |
| Q2 2026 | $164.3M | +12% |
| Q1 2026 | $164.4M | +17% |
| Q4 2025 | $164.2M | +17% |
| Q3 2025 | $151.2M | +17% |
| Q2 2025 | $147.1M | +18% |
| Q1 2025 | $140.7M | +11% |
| Q4 2024 | $140.7M | +6.1% |
IBEX's revenue has grown year over year for 10 quarters in a row: $175M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +1.4 points |
| Q2 2026 | 6% | -2.3 points |
| Q1 2026 | 9.8% | +0.4 points |
| Q4 2025 | 9.3% | +0.8 points |
| Q3 2025 | 9.1% | +2.1 points |
| Q2 2025 | 8.3% | -2 points |
| Q1 2025 | 9.5% | +0.6 points |
| Q4 2024 | 8.5% | +3.2 points |
IBEX's operating margin was 10% last quarter, up 1.4 points from the same quarter a year ago, near the top of its range since 2019.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over IBEX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over IBEX on profitability, with a higher operating margin.
IBEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | +14% |
| Q2 2026 | $21.7M | -4.9% |
| Q1 2026 | $6.6M | +85% |
| Q4 2025 | -$5.1M | -$1.9M |
| Q3 2025 | $8M | +94% |
| Q2 2025 | $22.8M | +50% |
| Q1 2025 | $3.6M | -63% |
| Q4 2024 | -$3.2M | +$1.4M |
IBEX has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
IBEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +187K shares |
| 1 year | +2.6% | +386K shares |
| 3 years | -21% | -3.9M shares |
| 5 years | -21% | -3.9M shares |
| Available history | -15% | -2.7M shares |
IBEX has 15M diluted shares, up 2.6% from a year ago, despite $16M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.5M |
| Q2 2026 | $4.2M |
| Q1 2026 | $4.6M |
| Q4 2025 | $2.8M |
| Q3 2025 | $2.8M |
| Q2 2025 | $1.6M |
| Q1 2025 | $25.1M |
| Q4 2024 | $46.6M |
IBEX spent $16M buying back its own shares over the past year, down 79% from the year before.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over IBEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
IBEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.2x | Net Cash |
IBEX has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
IBEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.3 | Overbought |
| Stochastic | 91.0 | Overbought |
IBEX's weekly RSI is 78 (overbought) and its Stochastic is 91 (overbought).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
IBEX PE vs Technology Sector
| Metric | IBEX | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 28x | 40% below |
| PE % | 73 | 37 | 36 pts above |
IBEX has the edge over MSFT on valuation relative to its sector.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
IBEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.8 | 17% above |
| 20 week MA | $40.6 | 35% above |
| 50 week MA | $35.5 | 54% above |
| 100 week MA | $32.3 | 70% above |
| 200 week MA | $25.5 | 115% above |
IBEX has the edge over MSFT on trend strength, trading above more of its moving averages.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT's trend is up, with a small recent dip: it's below only its 8-week average, and 27% above its 200-week average.
IBEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $20.1 | +30% |
| 2021 | $20.1 | $13.9 | -31% |
| 2022 | $13.9 | $25.6 | +84% |
| 2023 | $25.6 | $19.0 | -26% |
| 2024 | $19.0 | $21.4 | +13% |
| 2025 | $21.4 | $38.5 | +80% |
| 2026 YTD | $38.5 | $54.9 | +43% |
IBEX has the edge over MSFT on returns for 2026, with the stronger performance.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.